Each model independently rates ICON on a 1–5 star scale.
ICON plc is a well-established global contract research organization (CRO) headquering in Dublin, Ireland. It provides outsourced development and commercialization services to pharmaceutical and biotech companies. Generally well-regarded in the industry.
ICON is a blockchain platform with a strong reputation in the crypto community, known for its interoperability solutions. Limited specific data on regulation and support.
ICON plc (icon.com) is a major global provider of outsourced drug development and clinical research services. As a publicly traded company in a heavily regulated sector, it demonstrates strong trust and compliance, though specific trading and support details are less transparent for external parties.
ICON (icon.com) appears ambiguous and may refer to multiple entities. There’s insufficient verified information to assess this specific company’s licensing, products, support, or reputation. Providing neutral baseline scores until more details are available.
ICON at icon.com is unknown with no verifiable details on operations, licensing or reviews. Scores reflect lack of available information.
Quick answers based on live TrustRating data. How we score companies →
ICON is rated 3.2 out of 5 (“Average”) on TrustRating, based on 5 independent AI model assessments. The TrustScore combines real customer reviews with AI models that independently assess trust, regulation, support and reputation signals. Always do your own research before making a purchase or investment.
ICON currently has a TrustScore of 3.2 out of 5 (“Average”). The score blends verified customer reviews with assessments from multiple independent AI models, and it updates automatically as new reviews and scans come in. You can read exactly how scores are computed on our methodology page.